endocrine · Mechanism Report
Does the FSHB rs10835638 G allele increase FSH levels in women?
The FSHB rs10835638 G allele is associated with higher circulating follicle-stimulating hormone levels in women.
This is what AI claimed
The FSHB rs10835638 G allele is associated with higher follicle-stimulating hormone levels in women.
Executive summary
The claim states that the G allele at the FSHB promoter variant preserves a high-affinity LHX3 transcription factor binding site, maintaining stronger FSHB transcription and thus higher FSH synthesis. The mechanism graph frames this as a causal chain from the G allele to enhanced promoter activity to increased circulating FSH, which corresponds with observed hormonal and reproductive phenotypes in women.
Verified conclusion
The FSHB gene encodes the beta-subunit of follicle-stimulating hormone (FSH), which dictates the rate-limiting step of functional FSH synthesis. Genetic and molecular evidence robustly demonstrates that the FSHB promoter variant rs10835638 (often designated as c.-211G>T) is a major determinant of circulating FSH levels in women.
Molecular mechanism
- Transcription factor affinity: The G allele at rs10835638 represents the high-expression wild-type allele. It preserves a high-affinity binding site for LIM homeobox 3 (LHX3), a pituitary-specific transcription factor essential for activating FSHB gene expression.
- Transcriptional disruption: The alternative T allele introduces a sequence change that disrupts this LHX3 binding motif, impairing transcription. Because FSH beta-subunit synthesis is the rate-limiting step in mature heterodimeric FSH production, carriers of the G allele (particularly those with the GG genotype) maintain stronger transcriptional activation and subsequently release higher levels of circulating FSH into the bloodstream.
Clinical evidence and endocrine outcomes
- Hormonal phenotype: In premenopausal women, carrying the G allele is strongly associated with higher baseline FSH levels compared to those carrying the T allele.
- Downstream physiological effects: Large-scale genome-wide association studies (GWAS), including analyses from the UK Biobank, demonstrate that the elevated FSH output linked to the G allele manifests in distinct reproductive phenotypes:
- Menstrual cycle duration: The G allele is associated with shorter menstrual cycles.
- Age of menopause: It is genetically linked with an earlier onset of natural menopause.
- Reproductive conditions: The higher gonadotropin exposure associated with the G allele correlates with an increased risk of developing endometriosis.
Bottom line
The FSHB rs10835638 G allele is strongly associated with higher circulating follicle-stimulating hormone levels in women. Mechanistically, this is because the G allele preserves a high-affinity LHX3 transcription factor binding site in the FSHB promoter, maintaining robust transcriptional activation and hormone synthesis.
References
- FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men — pmc.ncbi.nlm.nih.gov
- Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health — pmc.ncbi.nlm.nih.gov
- Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health — academic.oup.com
- Increased Prevalance of the -211 T allele of follicle stimulating hormone (FSH) beta subunit promoter polymorphism and lower serum FSH in infertile men. — academic.oup.com
- Pharmacogenetics of follicle-stimulating hormone action — pmc.ncbi.nlm.nih.gov
- Molecular regulation of follicle-stimulating hormone synthesis, secretion and action. — pmc.ncbi.nlm.nih.gov
- Neuroendocrine, autocrine, and paracrine control of follicle-stimulating hormone secretion — pmc.ncbi.nlm.nih.gov
See a full patient report verified like this
Book a walkthrough